F5 and Rare hereditary thrombophilia: However, only 17% positive results (136/826) for low-risk thrombophilia led to a change in treatment, and merely 116 out of 714 (16%) carrierships of a heterozygous FVL mutation provided further guidance (Supplemental Table S2).